Fig. 2
From: Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Survival curve analysis of ICOS gene expression in different tumor types. (A): OS of CESC, COAD, HNSC, LGG, LUAD, OV, SARC, SKCM, THYM, UCEC, UVM. (B): DSS of BLCA, CESC, HNSC, LGG, LUAD, OV, SKCM, THYM, UCEC, UCS, UVM. Bladder Urothelial Carcinoma (BLCA), Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), Colon adenocarcinoma (COAD), Head and Neck squamous cell carcinoma (HNSC), Brain Lower Grade Glioma (LGG), Lung adenocarcinoma (LUAD), Ovarian serous cystadenocarcinoma (OV), Sarcoma (SARC), Skin Cutaneous Melanoma (SKCM), Thymoma (THYM), Uterine Corpus Endometrial Carcinoma (UCEC), Uterine Carcinosarcoma (UCS), Uveal Melanoma (UVM).